ADIL ▲ +41.5% - Adial Pharmaceuticals, Inc.
$ADIL - Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis
28-OCT-2026 04:02 PM ET
Share this post
More filings for $ADIL
ADIL ▼ -3.8% - Adial Pharmaceuticals IncNov 5, 2026ADIL ▼ -3.4% - Adial Pharmaceuticals, Inc.Sep 30, 2026$ADIL SEC Filing Update (01-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 2, 2026$ADIL SEC Filing Update (24-JUN-2026) | ThinkSabio - Stocks SimplifiedJun 24, 2026
View full $ADIL filing history →💬 Comments
Loading comments…
Leave a comment
